CVM

CEL-SCI Corp

• TipRanks·07/13 12:10

  CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study

• TipRanks·06/24 12:11

  CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026

• TipRanks·06/16 12:14

  CEL-SCI highlights dual-track strategy for Multikine

• Seeking Alpha·06/15 08:59

  CEL-SCI slides after pricing $2.5M best-efforts common stock offering at $1.00/share

• TipRanks·06/12 12:11

  CEL-SCI, Saudi Amarox to conduct signing ceremony for strategic agreement

• TipRanks·05/19 02:01

  Cel-Sci CEO Makes Bold Insider Move Signaling Growing Confidence

• TipRanks·05/18 12:10

  CEL-SCI reports Q2 EPS (67c) vs. ($2.33) last year

• Seeking Alpha·05/18 12:04

  Cel-Sci GAAP EPS of -$1.35

• Dow Jones·05/18 12:01

  *CEL-SCI 2Q Loss $5.5M >CVM

• Dow Jones·05/18 12:00

  Press Release: CEL-SCI Reports Fiscal Second Quarter 2026 Results

• TipRanks·05/15 02:06

  Cel-Sci Chief Makes Bold Insider Move, Tightening Alignment With Shareholders

• TipRanks·05/14 23:34

  Cel-Sci Forms Multikine Commercialization Partnership in Middle East

• Seeking Alpha·05/12 05:31

  CEL-SCI prices $7.2M offering at $1.20 per share

• TipRanks·05/12 02:55

  CEL-SCI 6M share Secondary priced at $1.20

• TipRanks·05/11 16:53

  CEL-SCI enters strategic agreement with Amarox over Multikine distribution